David W. Hockenbrocht, Chairman
President & CEO
Sparton Corporation

James J. Barry, Ph.D.
VP Corporate Research & Advanced
Technology Development

David S. Block, M.D., M.B.A.
Founder and CEO
Ruxton Pharmaceuticals, Inc.

David S. Bredt, M.D., Ph.D.
Vice President, Integrative Biology
Lilly Research Laboratories

Samuel Broder, M.D.
Chief Medical Officer
Celera Genomics

James Campbell, M.D.
Scientific Advisor
Interwest Partners

C. Thomas Caskey, M.D., FACP
Director/CEO-Elect & Chief Operating Officer
Brown Foundation Institute of Molecular Medicine
The University of Texas Health Science Center at Houston

Joseph A. Ciffolillo
Retired Medical Device Executive

Kenneth Fasman, Ph.D.
Director, Drug Development
Strategy and Performance
AstraZeneca PLC

Philip Goelet, Ph.D.
Red Abbey

Ms. Elizabeth Good
Managing Director
State of Maryland Venture Fund

Steve Gorlin
Principal
Gorlin Companies

Leroy E. Hood, M.D., Ph.D.
President
Institute for Systems Biology

Edwin M. Kania, Jr.
Managing Partner and Chairman
Flagship Ventures

Robert S. King
Managing Director -Investment Banking
MAXIM GROUP LLC

Tara Sharif, Ph.D.
Analyst – Investment Banking
MAXIM GROUP LLC

Chris Kroeger, M.D., M.B.A.
Principal
Aurora Funds, Inc.

Robert D. Mashal, M.D.
President & CEO
Alinea Pharmaceuticals

Troy Moore
Chief Technology Officer
Open Biosystems

Richard Newman
Vice President, Advanced Solutions
Welch Allyn, Inc.

James Niedel, M.D., Ph.D.
Managing Director
New Leaf Venture Partners, LLC

Stephen N. Oesterle, M.D.
Sr. Vice President for Medicine and Technology
Medtronic, Inc.

Christopher Shen, M.D., M.B.A.
Principal
NEA

Irving Sherman, M.D.
(Retired Neurosurgeon)

Craig R. Smith, M.D.
(Retired) Former Chairman,
President, & CEO – Guilford Pharmaceuticals
Williston Consulting, LLC

Joseph M. Smith, M.D., Ph.D., FACC
Senior Vice President
Chief Medical Officer
Cardiac Rhythm Management
Guidant Corporation